Rheumatologists' Aggressive Approach to SLE Treatment Targets Specific Patient Types with Biologics EXTON, PA, June 13, 2024 (GLOBE NEWSWIRE) -- Since 2021, the treatment options for systemic lupus erythematosus (SLE) and lupus nephritis (LN) have expanded with the approval of AstraZeneca’s...

Cutaneous Lupus Erythematosus (CLE) Patient Pool Analysis, Market Size and Market Forecast APAC - 2034 Dublin, March 25, 2024 (GLOBE NEWSWIRE) -- The "Cutaneous Lupus Erythematosus (CLE) Patient Pool Analysis, Market Size and Market Forecast APAC - 2034" report has been added to ...

DelveInsight Analyzes a Thriving Cutaneous Lupus Erythematosus Pipeline in the Coming Years as Key Pharma Companies Enter the Sphere Las Vegas, USA, Oct. 27, 2021 (GLOBE NEWSWIRE) -- DelveInsight Analyzes a Thriving Cutaneous Lupus Erythematosus Pipeline in the Coming Years as Key Pharma Companies Enter the Sphere The...

Zylö and Hoth Therapeutics Forge Partnership to Develop Endocannabinoid-Based Drug to Treat Lupus Zylö’s xerogel-derived delivery platform to be used to topically deliver the drug candidate Greenville, SC, Aug. 22, 2019 (GLOBE NEWSWIRE) -- Zylö Therapeutics, dedicated to bringing innovative...

Endocannabinoids Demonstrate Efficacy in Lupus Model Zylö’s Nanopod™ Delivery Technology Plays Key Role GREENVILLE, SC, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Zylö Therapeutics, a life science innovator bringing affordable first-to-market therapies to...